Tackling Salami Slicing and Indication Stacking in Orphan Drug Innovation Incentives - Bill of Health

Tackling Salami Slicing and Indication Stacking in Orphan Drug Innovation Incentives - Bill of Health

Are the incentive mechanisms for orphan drug development working as they should?

Orphan Drugs in Oncology

ICER Publishes White Paper Evaluating Reforms to Orphan Drug Development, Pricing, and Coverage - ICER

GHB, Orphans, and REMS: A Regulatory Love Story (Part 1)

Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies - KFF Health News

Incentives - Bill of Health

13. Incentivising the Development of Global Public Goods for Health, Ready for the Next Crisis? Investing in Health System Resilience

Abuses of Government Programs and Regulations - Drug Pricing Lab

Tackling Salami Slicing and Indication Stacking in Orphan Drug Innovation Incentives - Bill of Health

Tackling Salami Slicing and Indication Stacking in Orphan Drug Innovation Incentives - Bill of Health

Drugs For Rare Diseases Have Become Uncommonly Rich Monopolies